Handley S L, Singh L
Eur J Pharmacol. 1986 Aug 7;127(1-2):97-103. doi: 10.1016/0014-2999(86)90209-8.
The ability of beta-adrenoceptor agonists to potentiate the head-twitch response to 5-hydroxytryptophan (5-HTP) in mice was used to assess the in vivo sensitivity of beta-adrenoceptors 48 h after cessation of acute or chronic administration of desmethylimipramine (DMI) or iprindole (IPD). Neither acute nor chronic antidepressant administration significantly altered the head-twitch response to 5-HTP alone. Forty-eight hours after withdrawal from chronic but not acute pretreatment with DMI or IPD the potentiating effects of dobutamine, prenalterol and salbutamol were significantly decreased. This is consistent with a reduction in beta-adrenoceptor density and suggests that the 'spare' beta-adrenoceptor pool is small enough for this to result in functional subsensitivity. Implications of these findings are discussed.
使用β-肾上腺素能受体激动剂增强小鼠对5-羟色氨酸(5-HTP)的头部抽搐反应的能力,来评估去甲丙咪嗪(DMI)或茚满丙二胺(IPD)急性或慢性给药停止48小时后β-肾上腺素能受体的体内敏感性。急性或慢性抗抑郁药给药均未显著改变单独对5-HTP的头部抽搐反应。在从DMI或IPD的慢性而非急性预处理撤药48小时后,多巴酚丁胺、普瑞特罗和沙丁胺醇的增强作用显著降低。这与β-肾上腺素能受体密度降低一致,并表明“备用”β-肾上腺素能受体池足够小,以至于会导致功能性亚敏感性。讨论了这些发现的意义。